IL24 and cancer: A key element in MDA-7/IL-24’s effectiveness as an anticancer agent is its ability to be secreted by both normal and cancer cells resulting distinctively in the killing of primary and distant (metastatic) cancer cells [7,8,13,15,44,52,53,55,56].